Simulations Plus, Inc. (NASDAQ:SLP) Shares Purchased by Jane Street Group LLC

Jane Street Group LLC lifted its position in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 240.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 56,484 shares of the technology company's stock after purchasing an additional 39,915 shares during the period. Jane Street Group LLC owned 0.28% of Simulations Plus worth $1,575,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the company. Jones Financial Companies Lllp increased its holdings in Simulations Plus by 53.6% during the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock valued at $34,000 after buying an additional 427 shares during the period. Johnson Financial Group Inc. bought a new stake in Simulations Plus during the fourth quarter valued at about $39,000. Tower Research Capital LLC TRC boosted its position in Simulations Plus by 42.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock valued at $72,000 after purchasing an additional 764 shares in the last quarter. AlphaQuest LLC boosted its position in Simulations Plus by 502.9% during the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock valued at $75,000 after purchasing an additional 2,243 shares in the last quarter. Finally, KLP Kapitalforvaltning AS bought a new stake in Simulations Plus during the fourth quarter valued at about $86,000. Hedge funds and other institutional investors own 78.08% of the company's stock.

Simulations Plus Trading Down 1.2%

Shares of NASDAQ SLP traded down $0.38 during midday trading on Wednesday, reaching $31.70. The company had a trading volume of 410,169 shares, compared to its average volume of 214,434. The business's 50-day simple moving average is $29.28 and its 200 day simple moving average is $30.32. The stock has a market cap of $637.52 million, a P/E ratio of 79.25 and a beta of 1.10. Simulations Plus, Inc. has a 1 year low of $23.01 and a 1 year high of $50.98.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. The business had revenue of $22.43 million during the quarter, compared to analysts' expectations of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business's quarterly revenue was up 22.5% on a year-over-year basis. During the same quarter last year, the company posted $0.20 earnings per share. Analysts predict that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms recently commented on SLP. StockNews.com raised shares of Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. KeyCorp increased their target price on shares of Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a research report on Wednesday, April 16th. Two research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Simulations Plus has an average rating of "Moderate Buy" and an average price target of $50.00.

Insider Activity

In other news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $33.51, for a total value of $670,200.00. Following the completion of the transaction, the director now owns 3,344,157 shares of the company's stock, valued at $112,062,701.07. The trade was a 0.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 19.40% of the company's stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.